Daily Round Up 7/27/16: Blackrock Debt Strategies Fund, Bank Of Commerce, Nuveen Global Equity Income Fund

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on 7/27/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:

Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early August.

On Today's Tables:

Insider trades were rated Significant at:

  • Nuveen Global Equity Income Fund (NYSE:JGV);
  • Blackrock Debt Strategies Fund (NYSE:DSU), and;
  • Bank Of Commerce (NASDAQ:BOCH).

Insider trades were rated Nearly Significant at:

  • Access National (NASDAQ:ANCX).

Insider trades were considered Insignificant at:

  • Upland Software (NASDAQ:UPLD);
  • True Nature Holding (OTCQB:TNTY);
  • Thunder Mountain Gold (OTCQB:THMG);
  • Southern National Bancorp (NASDAQ:SONA);
  • Contrafect (NASDAQ:CFRX);
  • Ultratech (NASDAQ:UTEK);
  • Rsp Permian (NYSE:RSPP);
  • Pultegroup (NYSE:PHM);
  • Nci Building Sys (NYSE:NCS);
  • Lennox Intl (NYSE:LII);
  • Alphabet (NASDAQ:GOOG);
  • Dolby Labs (NYSE:DLB);
  • Bloomin Brands (NASDAQ:BLMN), and;
  • Almost Family (NASDAQ:AFAM).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Abbott Laboratories (NYSE:ABT).

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 White Miles D CB,CEO Abbott Laboratories ABT AB $31,622,769
2 Saba Capital Mgt BO Blackrock Debt Strategies Fund DSU B $362,000
3 Esw Capital BO Upland Software UPLD B $168,964
4 Call Neil J DIR Southern National Bancorp SONA JB* $99,990
5 Moore Mark D PR Access National ANCX B $71,229
6 Bulldog Investors BO Nuveen Global Equity Income Fund JGV B $54,175
7 Gilman Steven C CEO,DIR Contrafect CFRX JB* $49,600
8 Crone Phillip DIR True Nature Holding TNTY JB* $45,468
9 Beckman Paul Albert IR,BO Thunder Mountain Gold THMG JB* $40,000
10 Gibson Joseph DIR Bank Of Commerce BOCH B $32,600

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Cd & R Assoc VIII BO Nci Building Sys NCS JS* $205,053,472
2 Page Lawrence CEO,DIR,BO Alphabet GOOG AS,JS* $22,848,158
3 Carlson Capital BO Ultratech UTEK S,JS* $19,863,126
4 Dugas Richard J Jr CEO,DIR Pultegroup PHM S $5,339,005
5 Dolby Dagmar BO Dolby Labs DLB AS $5,003,981
6 Bluedorn Todd M CB,CEO Lennox Intl LII AS $4,537,018
7 Swan Robert Holmes DIR EBAY EBAY AS $1,532,340
8 Sullivan Chris Thomas DIR Bloomin Brands BLMN AS $1,508,045
9 North Tide Capital BO Almost Family AFAM S $1,463,141
10 Collins Ted Jr DIR,BO Rsp Permian RSPP AS $1,429,705 | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.